Contrasting Concord Medical Services (NYSE:CCM) & AirSculpt Technologies (NASDAQ:AIRS)

Concord Medical Services (NYSE:CCMGet Rating) and AirSculpt Technologies (NASDAQ:AIRSGet Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings.

Earnings & Valuation

This table compares Concord Medical Services and AirSculpt Technologies’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Concord Medical Services $76.21 million 0.92 -$42.59 million N/A N/A
AirSculpt Technologies $133.32 million 3.25 $10.55 million N/A N/A

AirSculpt Technologies has higher revenue and earnings than Concord Medical Services.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Concord Medical Services and AirSculpt Technologies, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concord Medical Services 0 0 0 0 N/A
AirSculpt Technologies 0 1 3 0 2.75

AirSculpt Technologies has a consensus price target of $19.50, indicating a potential upside of 150.64%. Given AirSculpt Technologies’ higher probable upside, analysts plainly believe AirSculpt Technologies is more favorable than Concord Medical Services.

Insider and Institutional Ownership

0.3% of Concord Medical Services shares are owned by institutional investors. Comparatively, 64.9% of AirSculpt Technologies shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by company insiders. Comparatively, 77.9% of AirSculpt Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Concord Medical Services and AirSculpt Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Concord Medical Services N/A N/A N/A
AirSculpt Technologies N/A -8.09% -3.50%

Summary

AirSculpt Technologies beats Concord Medical Services on 7 of the 9 factors compared between the two stocks.

About Concord Medical Services

(Get Rating)

Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

About AirSculpt Technologies

(Get Rating)

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.